Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2101032	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	New Drug Application	2021-04-15		Hutchison MediPharma Co Ltd			view
CXHS2400021	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	New Drug Application	2024-03-27		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
CYHB2102296	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2021-12-14		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
JXHL2200063	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2022-03-22		AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd			view
CXHS2400133	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	New Drug Application	2024-12-31		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
CXHL2101033	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	New Drug Application	2021-04-15		Hutchison MediPharma Co Ltd			view
CYHB2400430	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2024-03-27		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
JXHL2200064	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2022-03-22		AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd			view
CXHS2400134	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	New Drug Application	2024-12-31		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
JXHB2300086	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Supplementary Application	2023-05-25		AstraZeneca AB			view
JXHL2200062	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Import Drug Application	2022-03-22		AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd			view
CXHS2400022	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	New Drug Application	2024-03-27		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
CXHL2100211	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	New Drug Application	2021-03-31	和记黄埔医药（上海）有限公司	Hutchison MediPharma Co Ltd	In Review	2021-03-30	view
JXHB2500064	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Supplementary Application	2025-05-10		AstraZeneca AB			view
CYHB2102295	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2021-12-14		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
CYHB2400431	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	Supplementary Application	2024-03-27		Hutchison MediPharma Co Ltd;Shanghai STA Pharmaceutical PRODUCT Co Ltd			view
CXHL2100210	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(1)	New Drug Application	2021-03-31	和记黄埔医药（上海）有限公司	Hutchison MediPharma Co Ltd	In Review	2021-03-30	view
JXHB2300085	赛沃替尼片	savolitinib	Tablet	Chemical Drugs(2.4)	Supplementary Application	2023-05-25		AstraZeneca AB			view